Arrhythmogenic cardiomyopathy: from concealed phase to refractory failure: a nine-year case study illustrating diagnostic evolution and biventricular progression

Authors

  • Lyudmila Kolochey Department of Internal Medicine, Grodno State Medical University, Grodno, Belarus
  • Saarah D. Allahudeen Department of Internal Medicine, Grodno State Medical University, Grodno, Belarus
  • Ibrahim R. R. Haq Department of Internal Medicine, Grodno State Medical University, Grodno, Belarus
  • Zahra F. Z. Fayik Department of Internal Medicine, Grodno State Medical University, Grodno, Belarus
  • Udani D. M. Sarathchandra Department of Internal Medicine, Grodno State Medical University, Grodno, Belarus

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261353

Keywords:

Arrhythmogenic cardiomyopathy, Coronary angiography, Ventricular fibrillation, implantable cardioverter-defibrillator.

Abstract

Arrhythmogenic cardiomyopathy (ACM) is a type of cardiomyopathy characterized by fibrofatty replacement of the right ventricular myocardium and associated with life-threatening arrhythmias. The criteria of the diagnosis of ACM are based on the estimates of structural changes in the right ventricular myocardium, electrocardiographic changes, fibrofatty dystrophy in the course of a histological investigation, and a family history of the disease. The diagnosis can be a challenging task as there are no pathognomonic clinical markers, which makes differential diagnosis of ACM with secondary myocardial pathology more difficult to perform. The article presents a nine-year-old case study of a young male patient with ACM, dominated by life-threatening ventricular arrhythmias and episode of resuscitated sudden cardiac death despite optimal medical therapy and cardioverter-defibrillator implantation.

 

References

Pilichou K, Thiene G, Bauce B, Rigato I, Lazzarini E, Migliore F, et al. Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis. 2016;11(1):33.

Romero J, Mejia-Lopez E, Manrique C, Lucariello R. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review. Clin Med Insights Cardiol. 2013;7:97.

Zorzi A, Cipriani A, Bariani R, Pilichou K, Corrado D, Bauce B. Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy. Curr Cardiol Rep. 2021;23(6):57.

Haugaa KH, Haland TF, Leren IS, Saberniak J, Edvardsen T. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016;18(7):965-72.

Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pillichou K, et al. Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2010;55(6):587-97.

Cerrone M, Delmar M. Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome. Trends Cardiovasc Med. 2014;24(5):184-90.

Asimaki A, Kleber AG, Saffitz JE. Pathogenesis of Arrhythmogenic Cardiomyopathy. Can J Cardiol. 2015;31(11):1313.

Romero J, Mejia-Lopez E, Manrique C, Lucariello R. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review. Clin Med Insights Cardiol. 2013;7:97-114.

Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P, et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123(23):2701-9.

Graziano F, Zorzi A, Ungaro S, Bauce B, Rigato I, Cipriani A, et al. The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes. Rev Cardiovasc Med. 2024;25(9):348.

Corrado D, Zorzi A, Cipriani A, Bauce B, Bariani R, Beffagna G, et al. Evolving diagnostic criteria for arrhythmogenic cardiomyopathy. J Am Heart Assoc. 2021;10(18).

Asimaki A, Tandri H, Duffy ER, Winterfield JR, MacKey-Bojack S, Picken MM, et al. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(5):743-52.

Haugaa KH, Bundgaard H, Edvardsen T, Eschen O, Gilljam T, Hansen J, et al. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries. Scand Cardiovasc J. 2015;49(6):299-307.

Martini M, Rigato I, Masini M, De Lazzari M, Mattesi G, Pilichou K, et al. Risk stratification in arrhythmogenic cardiomyopathy: scoring or personalized medicine? Eur Heart J Supplements. 2025;27(Supplement_1):i36-9.

Corrado D, Wichter T, Link MS, Hauer RNW, Marchlinski FE, Anastasakis A, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: An international task force consensus statement. Circulation. 2015;132(5):441-53.

Downloads

Published

2026-04-29

How to Cite

Kolochey, L., Allahudeen, S. D., Haq, I. R. R., Fayik, Z. F. Z., & Sarathchandra, U. D. M. (2026). Arrhythmogenic cardiomyopathy: from concealed phase to refractory failure: a nine-year case study illustrating diagnostic evolution and biventricular progression. International Journal of Research in Medical Sciences, 14(5), 2084–2088. https://doi.org/10.18203/2320-6012.ijrms20261353

Issue

Section

Case Reports